Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 0.95B P/E - EPS this Y 12.40% Ern Qtrly Grth -
Income -43.34M Forward P/E -21.37 EPS next Y 22.20% 50D Avg Chg -7.00%
Sales 138.89M PEG -1.78 EPS past 5Y - 200D Avg Chg 25.00%
Dividend N/A Price/Book 9.18 EPS next 5Y 8.90% 52W High Chg -17.00%
Recommedations 1.70 Quick Ratio 8.02 Shares Outstanding 41.06M 52W Low Chg 121.00%
Insider Own 2.40% ROA -15.12% Shares Float 37.82M Beta 1.21
Inst Own 97.99% ROE -32.38% Shares Shorted/Prior 2.53M/1.95M Price 24.57
Gross Margin 78.78% Profit Margin -31.20% Avg. Volume 448,664 Target Price 26.88
Oper. Margin -32.18% Earnings Date Apr 29 Volume 271,300 Change -4.32%
About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

SI-BONE, Inc. News
03/04/24 SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
02/28/24 When Will SI-BONE, Inc. (NASDAQ:SIBN) Become Profitable?
02/27/24 Q4 2023 SI-BONE Inc Earnings Call
02/26/24 SI-BONE Inc (SIBN) Reports Record Revenue Growth in Q4 and Full Year 2023
02/26/24 SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
02/21/24 How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
02/20/24 Earnings Preview: Masimo (MASI) Q4 Earnings Expected to Decline
02/19/24 Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
02/05/24 SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024
01/31/24 Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
01/30/24 SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application
01/22/24 15 Small-Cap Stocks with High Potential
01/08/24 SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023
01/05/24 SI-BONE Inc Director Davis Timothy E JR Sells 9,900 Shares
11/30/23 Si-Bone (SIBN) Crossed Above the 50-Day Moving Average: What That Means for Investors
11/21/23 Insider Sell: President, Commercial Ops Anthony Recupero Sells 8,457 Shares of SI-BONE Inc (SIBN)
11/14/23 SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
11/07/23 SI-BONE, Inc. (NASDAQ:SIBN) Q3 2023 Earnings Call Transcript
11/07/23 Q3 2023 SI-BONE Inc Earnings Call
11/06/23 SI-BONE Inc (SIBN) Reports Record Q3 2023 Financial Results, Raises Annual Guidance
SIBN Chatroom

User Image Thestocktraderhubzee Posted - 19 hours ago

$SIBN Piper Sandler Initiates Coverage On SI-BONE with Overweight Rating, Announces Price Target of $25

User Image insiderbuyingselling Posted - 2 weeks ago

$SIBN new insider selling: 2500 shares. http://insiderbuyingselling.com/?t=SIBN

User Image Mr_Gribble Posted - 2 weeks ago

$SIBN Let's go!

User Image Stock_Titan Posted - 3 weeks ago

$SIBN SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024 https://www.stocktitan.net/news/SIBN/si-bone-to-present-at-barclays-26th-annual-global-healthcare-38wffrubi957.html

User Image StockInvest_us Posted - 4 weeks ago

Signal alert: $SIBN - Oversold Trend Short (Undervalued) https://stockinvest.us/l/saTY6rWmea

User Image BioGem Posted - 1 month ago

$SIBN Many critical negatives for such a high mkt cap = high downside risk. -Shockingly low gross margin in Q4 of 74%. -Expected growth in 2024 is quite tepid near 18%, which is a screeching halt from the 31% in 2023. -Gross margin is markedly dropping from 85% in 22, to 79% in 23, to estimate of 78% in 2024. -Their expectation is for a 9% increase in op ex, which estimates an operating loss near -43M in 2024. -Continuous large insider sales every quarter. -Steadily increasing # of dilutive outstanding shares. -High short interest = consensus of poor stock performance.

User Image Stocksrunner Posted - 1 month ago

📉 Today's Top Laggards in the Buzz: $PRGO - Perrigo Co. plc experiences a downturn, initiating Project Energize to improve efficiency and cutting jobs, with FY24 guidance below estimates. $AJX - Great Ajax reduces dividend by 9% to $0.10, signaling financial adjustments amid management transition with Rithm affiliate. $SIBN - SI-BONE stock analyzed by 4 analysts with diverse perspectives, highlighting potential uncertainties impacting investor sentiment. $CAN - Canaan Inc. reports Q4 results with Non-GAAP EPS of -$0.30 missing estimates, affecting investor confidence. $HLX - Helix Energy Solutions Group faces challenges as Q4 earnings reveal Non-GAAP EPS of $0.06, falling slightly short of expectations. 📊 Traders, stay informed and monitor these developments closely.

User Image RocketThief Posted - 1 month ago

$SIBN starter - extremely solid company. Will probably get bought within 1-2 years imo

User Image Ninja_Tradez Posted - 1 month ago

📢 $SIBN - Morgan Stanley Maintains Overweight on SI-BONE, Raises Price Target to $26 https://newsfilter.io/a/3dc74c9886356024089f968657b28789

User Image OpenOutcrier Posted - 1 month ago

$SIBN (-7.5% pre) SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance https://ooc.bz/l/26209

User Image epsguid Posted - 1 month ago

$SIBN reported a loss of $0.27, consensus was ($0.29) via @eWhispers #epsbeat http://eps.sh/d/sibn

User Image DonCorleone77 Posted - 1 month ago

$SIBN SI-Bone sees FY24 revenue $162M-165M, consensus $159.06M SI-BONE expects 2024 worldwide revenue of $162 million to $165 million, implying year-over-year growth of ~17% to ~19%. SI-BONE estimates fiscal year 2024 gross margin to be ~78% and operating expenses growth to be ~9%. Based on these assumptions, SI-BONE expects significant year-over-year improvement in Adjusted EBITDA loss for full year 2024.

User Image DonCorleone77 Posted - 1 month ago

$SIBN SI-Bone reports Q4 EPS (27c), consensus (28c) Reports Q4 revenue $38.9M, consensus $37.61M. "2023 was a year of records for us, as our annual worldwide revenue growth exceeded 30%, led by over 32% procedure volume growth in the U.S. I am proud of our team's stellar execution as we supported a record 1,600 U.S. physicians to help improve the lives of nearly 15,000 patients in the U.S., while driving substantial operating leverage and reduction in cash usage," said Laura Francis, Chief Executive Officer. "I expect 2024 to be an exciting year for us as we capitalize on favorable demand dynamics, launch products across each of our target markets, and make significant progress toward our Adjusted EBITDA breakeven goal."

User Image Stock_Titan Posted - 1 month ago

$SIBN SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance https://www.stocktitan.net/news/SIBN/si-bone-inc-reports-record-fourth-quarter-and-full-year-2023-w39thn0uxnkc.html

User Image insiderbuyingselling Posted - 1 month ago

$SIBN new insider selling: 335 shares. http://insiderbuyingselling.com/?t=SIBN

User Image Stock_Titan Posted - 1 month ago

$SIBN SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024 https://www.stocktitan.net/news/SIBN/si-bone-to-report-fourth-quarter-and-full-year-2023-financial-ehulb62m4a8k.html

User Image DonCorleone77 Posted - 01/30/24

$SIBN SI-Bone receives FDA 510k clearance for smaller diameter of iFuse Implant SI-BONE announces FDA 510(k) premarket clearance of the iFuse Bedrock Granite Implant System in a smaller diameter with both an expanded indication in pediatric patients and an expanded application that includes use in the S1 trajectory. When placed across the SI joint, the Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for multi-segment spinal fusion. This 510(k) clearance follows the initial clearance of the iFuse Bedrock Granite System in May 2022 that included implants of 10.5 mm and 11.5 mm in diameter.

User Image cctranscripts Posted - 2 months ago

BlackRock, Inc. just provided an update on share ownership of SI-BONE, Inc. https://www.conferencecalltranscripts.org/summary/?id=12891566 $SIBN

User Image cctranscripts Posted - 2 months ago

Israel A. Englander just provided an update on share ownership of SI-BONE, Inc. https://www.conferencecalltranscripts.org/summary/?id=12884292 $SIBN

User Image cctranscripts Posted - 2 months ago

SI-BONE, Inc. insider just picked up 21,111 shares https://www.conferencecalltranscripts.org/summary/?id=12855065 $SIBN

User Image tickeron Posted - 2 months ago

This is amazing! What do you think? $SIBN entered a Downtrend because Momentum Indicator dropped below the 0 level. View odds of downtrend. https://srnk.us/go/4964619

User Image EarningsInsider Posted - 2 months ago

$SIBN updates FY 2023 guidance to EPS and revenue guidance to $138.5 million-$138.7 million. www.marketbeat.com/stocks/NASDAQ/SIBN/earnings

User Image EarningsInsider Posted - 2 months ago

$SIBN updates Q4 2023 guidance to EPS and revenue guidance to $38.5 million-$38.7 million. www.marketbeat.com/stocks/NASDAQ/SIBN/earnings/

User Image ErmaLong Posted - 2 months ago

$ATRC $GBTC $CVRX $SIBN Started trading over 4 months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts.. Highly recommended! It's free joining!~...💖 top-stocks-winning-great-us.blogspot.com/2023/11/blog-post.html

User Image DonCorleone77 Posted - 2 months ago

$SIBN SI-Bone sees Q4 revenue $38.5M-$38.7M, consensus $36.54M U.S. revenue expected to be in the range of $36.5-$36.6 million, representing growth of approximately 22% compared to the prior year period; Ended the quarter with approximately 1,130 active surgeons in the U.S., representing growth of approximately 22% compared to the prior year period

User Image DonCorleone77 Posted - 2 months ago

$SIBN SI-Bone sees 2023 revenue $138.5M-$138.7M, consensus $136.14M U.S. revenue expected to be in the range of $130.5-$130.6 million, representing growth of approximately 32% compared to the prior year period Cash and marketable securities are expected to be approximately $166.0 million as of December 31, 2023, implying net cash usage of $0.8 million in the fourth quarter.

User Image cctranscripts Posted - 2 months ago

Si-Bone Announces Preliminary Revenue For The Fourth Quarter And Full Year 2023 https://www.conferencecalltranscripts.org/summary/?id=12849332 $SIBN

User Image Last10K Posted - 2 months ago

$SIBN just filed with the SEC a Earnings Release, a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/SIBN/0001459839-24-000003.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=SIBN

User Image risenhoover Posted - 2 months ago

$SIBN / SI-BONE files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 8, 2024 SI-BONE, INC. (Ex https://fintel.io/doc/sec-si-bone-inc-1459839-8k-2024-january-08-19730-9274?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Stock_Titan Posted - 2 months ago

$SIBN SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023 https://www.stocktitan.net/news/SIBN/si-bone-announces-preliminary-revenue-for-the-fourth-quarter-and-nocc2yzcgo9n.html

Analyst Ratings
Piper Sandler Overweight Mar 28, 24
Morgan Stanley Overweight Feb 27, 24
Cantor Fitzgerald Overweight Feb 27, 24
Truist Securities Buy Feb 27, 24
Truist Securities Buy Dec 22, 23
Needham Buy Dec 4, 23
Cantor Fitzgerald Overweight Nov 7, 23
Morgan Stanley Overweight Nov 7, 23
Needham Buy Nov 7, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
DUNN JEFFREY W Director Director Feb 02 Sell 20.2968 335 6,799 44,383 02/05/24
Davis Timothy E JR Director Director Jan 02 Option 3.24 21,111 68,400 43,472 01/09/24
Davis Timothy E JR Director Director Jan 02 Sell 20.9314 9,900 207,221 22,361 01/04/24
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Jan 02 Sell 20.9253 1,936 40,511 198,903 01/04/24
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Jan 02 Sell 20.924 1,470 30,758 147,268 01/04/24
DUNN JEFFREY W Director Director Nov 16 Sell 17.69 7,965 140,901 44,718 11/20/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Nov 16 Sell 17.66 8,457 149,351 200,839 11/20/23
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Nov 16 Sell 17.58 1,733 30,466 148,738 11/20/23
DUNN JEFFREY W Director Director Oct 21 Sell 17.52 406 7,113 52,683 11/06/23
DUNN JEFFREY W Director Director Oct 02 Sell 21.19 20,000 423,800 69,645 10/04/23
DUNN JEFFREY W Director Director Oct 02 Option 4.32 20,000 86,400 89,645 10/04/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Oct 02 Sell 21.1576 1,712 36,222 209,296 10/04/23
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Oct 02 Sell 21.1494 1,244 26,310 150,471 10/04/23
DUNN JEFFREY W Director Director Sep 01 Sell 22.61 20,000 452,200 69,645 09/06/23
DUNN JEFFREY W Director Director Sep 01 Option 4.32 20,000 86,400 89,645 09/06/23
DUNN JEFFREY W Director Director Aug 11 Sell 21.48 20,000 429,600 77,609 08/15/23
DUNN JEFFREY W Director Director Aug 11 Option 4.32 20,000 86,400 97,609 08/15/23
DUNN JEFFREY W Director Director Aug 02 Sell 25.0763 406 10,181 77,609 08/03/23
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Jul 03 Sell 26.7032 1,244 33,219 153,448 07/05/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Jul 03 Sell 26.6848 1,712 45,684 219,490 07/05/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Jun 15 Sell 28.59 48 1,372 221,202 06/20/23
HILLEMAN JERYL L Director Director Jun 15 Sell 28.37 4,162 118,076 15,349 06/20/23
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Jun 07 Sell 28.00 3,272 91,616 154,692 06/09/23
DUNN JEFFREY W Director Director May 09 Sell 22 272,753 6,000,566 85,166 05/10/23
DUNN JEFFREY W Director Director May 09 Option 3.42 272,753 932,815 357,919 05/10/23
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Apr 03 Sell 19.2995 1,229 23,719 159,697 04/05/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Apr 03 Sell 19.2816 1,712 33,010 227,815 04/05/23
DUNN JEFFREY W Director Director Feb 03 Sell 18.22 302 5,502 111,371 02/07/23
DUNN JEFFREY W Director Director Jan 17 Sell 16.1435 1,739 28,074 101,992 01/18/23
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr Jan 17 Sell 16.1821 399 6,457 172,108 01/18/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Jan 17 Sell 16.1 1,948 31,363 237,901 01/18/23
DUNN JEFFREY W Director Director Oct 17 Sell 18.3406 2,114 38,772 113,842 10/18/22
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Oct 17 Sell 18.5218 587 10,872 168,676 10/18/22
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr Oct 17 Sell 18.3869 355 6,527 119,539 10/18/22
DUNN JEFFREY W Director Director Aug 16 Sell 17.29 7,965 137,715 124,027 08/17/22
FRANCIS LAURA Chief Executive Offi.. Chief Executive Officer Aug 16 Sell 17.29 5,248 90,738 326,147 08/17/22
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Aug 16 Sell 17.29 5,463 94,455 169,263 08/17/22
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr Aug 16 Sell 17.29 3,475 60,083 119,894 08/17/22
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Aug 16 Sell 17.29 1,709 29,549 89,487 08/17/22
DUNN JEFFREY W Director Director Jul 15 Sell 14.2794 2,116 30,215 135,267 07/18/22
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr Jul 15 Sell 14.2794 355 5,069 123,369 07/18/22
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Jun 15 Sell 14.28 588 8,397 174,726 07/18/22
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer May 16 Sell 12.58 4,111 51,716 91,196 05/17/22
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops May 16 Sell 12.58 5,466 68,762 175,214 05/17/22
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr May 16 Sell 12.58 3,466 43,602 123,724 05/17/22
FRANCIS LAURA Chief Executive Offi.. Chief Executive Officer May 16 Sell 12.58 4,805 60,447 331,395 05/17/22
DUNN JEFFREY W Director Director May 16 Sell 12.58 5,608 70,549 137,383 05/17/22
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr Apr 18 Sell 19.9238 349 6,953 126,056 04/20/22
DUNN JEFFREY W Director Director Apr 18 Sell 19.9238 1,474 29,368 152,285 04/20/22
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Apr 18 Sell 19.9238 577 11,496 179,545 04/20/22